Track the Elekta AB (publ) stock price and the full insider trade history of the company, a listed issuer based in Finland. Shares are quoted on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Elekta AB (publ) has published 13 public disclosures. Market capitalisation: €18.6bn. The latest transaction was filed on 6 July 2026 (Purchase). Among the most active insiders: Jan De Witte. The full history is openly available.
13
Insider Decl.
n/a
Thresholds
€499,021
13 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Elekta AB (publ) Hold (neutral), based on 14 analysts. Average price target: SEK 59.96.
28Σ signal
Buys €499,021n/a Sells
Fundamental score
Ranked 21,794 of 29,062 companies
34.5
score / 100
Value
40
Quality
29
FCF yld6.7%
Earn yld-2.5%
EV/EBITDA19.9x
ROE-4.3%
Gross mgn37%
Net mgn-3.1%
Debt/EBITDA5.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
6,000 shares@ €4.27290.0001% mcap100.0% of flowAktieISINISIN SE0000163628FI:A003N311-1
13 of 13 declarations
About Elekta AB (publ)
Elekta AB (publ) is a Swedish company focused on developing solutions for cancer treatment and neurological care. It is listed on the Stockholm Stock Exchange under the symbol XSTO.